BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14748875)

  • 21. Using a surveillance system to identify and treat newly acquired hepatitis C infection.
    Walsh N; Lim M; Hellard M
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1891-4. PubMed ID: 19120877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988-2015.
    Richard JL; Schaetti C; Basler S; Mäusezahl M
    Swiss Med Wkly; 2018; 148():w14619. PubMed ID: 29698546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17.
    Talaat M; Afifi S; Reaves EJ; Abu Elsood H; El-Gohary A; Refaey S; Hammad R; Abdel Fadeel M; Kandeel A
    BMC Infect Dis; 2019 Feb; 19(1):159. PubMed ID: 30764780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of hepatitis C virus infection in Sweden.
    Duberg A; Janzon R; Bäck E; Ekdahl K; Blaxhult A
    Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004.
    Wu HX; Wu J; Wong T; Andonov A; Li Q; Dinner K; Donaldson T; Paton S;
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):167-74. PubMed ID: 17308895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee.
    McDonald AM; Gertig DM; Crofts N; Kaldor JM
    Am J Public Health; 1994 Dec; 84(12):1923-8. PubMed ID: 7998631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of hepatitis C in Australia.
    Kaba S; Dutta U; Byth K; Crewe EB; Khan MH; Coverdale SA; Lin R; Liddle C; Farrell GC
    J Gastroenterol Hepatol; 1998 Sep; 13(9):914-20. PubMed ID: 9794190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying newly acquired cases of hepatitis C using surveillance: a literature review.
    Sacks-Davis R; VAN Gemert C; Bergeri I; Stoove M; Hellard M
    Epidemiol Infect; 2012 Nov; 140(11):1925-34. PubMed ID: 22651915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.
    Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ahmad F; Boxall E; Hale A; Hollyoak V; Ibrahim IB; Irving W; Meigh R; Mutton KJ; Patel BC; Paver WK; Pugh S; Taylor C; Turner AJ; Ramsay ME
    Epidemiol Infect; 2007 Apr; 135(3):417-26. PubMed ID: 16836798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilizing Electronic Laboratory Reporting Data to Assess the Burden of Hepatitis C in Arizona.
    Tsang CA; Khan MA; Brady SM; Erhart LM; Komatsu KK
    J Public Health Manag Pract; 2020; 26(6):562-569. PubMed ID: 31094863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low risk of sexual transmission of hepatitis C virus in Somalia.
    Watts DM; Corwin AL; Omar MA; Hyams KC
    Trans R Soc Trop Med Hyg; 1994; 88(1):55-6. PubMed ID: 8154002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of intrafamilial transmission of hepatitis C virus and low risk for sexual transmission in rural central Africa indicate a cohort effect.
    Ndong-Atome GR; Njouom R; Padilla C; Bisvigou U; Makuwa M; Kazanji M
    J Clin Virol; 2009 Aug; 45(4):349-53. PubMed ID: 19473878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C oubreaks in Poland in 2003-2013. Medical procedures as a dominant route of HCV transmission.
    Stępień M; Rosińska M
    Przegl Epidemiol; 2015; 69(3):465-72, 585-90. PubMed ID: 26519841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
    Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
    Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based study of the epidemiology of hepatitis C in a North American population.
    Uhanova J; Tate RB; Tataryn DJ; Minuk GY
    J Hepatol; 2012 Oct; 57(4):736-42. PubMed ID: 22668641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.